Lilly Likes Concept Of Low-Cost Brand Alternatives As ‘Glide Path’ To No Rebates
Approach could be useful for quickly lowering the cost of insulins, Express Scripts’ Miller points out.
You may also be interested in...
Approach has been endorsed by Express Scripts as more workable solution than trying to cut list prices for drugs already on the market.
Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on existing brands, PBM says.
HHS endorsement of company-sponsored discount programs for cash-paying customers with Medicare would be preferable to lowering list pricing.